PINK1 and glioblastoma: For example, increased PINK1 expression in liver, kidney, pancreatic and endometrial cancers was associated with improved overall survival, while breast, cervical, ovarian, lung, glioblastoma, and melanoma cancers were associated with a poor prognosis.